post

VTE Risk and Prophylaxis: Devil in the Details

VTE is a problem – there is definitely a risk of hospitalized patients acquiring and either dying or developing complications from VTE. The problem is that “hospitalized patients” includes very heterogeneous groups of patients.  We know that the higher risk groups DO benefit from appropriate VTE prophylaxis: Orthopaedic surgical patients General and gynaecological surgery Oncological […]

post

Old Doc, New Drug: Gliflozins

Quick confession: I have never read or seen anything about Harry Potter in my life.  It isn’t because I am opposed to the Rowling machine.  I just grew up at the time before Harry and then had kids who missed the last few episodes…  I guess I have a lot to look forward to, one day […]

post

Old Doc, New Drug: Ticagrelor

We all love to interfere with the clotting cascade in modern medicine, and this is a new way to do so!  Yet another unpronounceable new drug.  Ti-CAG-re-lor  is the latest in the family of drugs [cyclopentyltriazolopyrimidines.. forget that word immediately ] that stop clots and start bleeding.  I like to call it “tiger claw” and everyone around […]

post

Old Doc, New Drug: Umeclidinium

When I first saw the name of this medication… I honestly thought that some smart physicist had discovered a new element way down the bottom of the period table.  Naturally, being a total chemistry nerd, I was excited… until I realised that it was in fact just another boring drug to treat the most mundane […]

post

Clinical Case 145: Stump the Chumps Perth

I have a special treat for you today!  One of the best things about FOAMed is the collaborations with great clinicians and teachers.  I was lucky enough to be able to get together with a few excellent minds to present this clinical case at the recent Australian Medical Students Society Conference, in Perth. WA. If […]